KBC Group: Third-quarter result of 601 million euros
Outside trading hours - Regulated information*
Brussels, 12 November 2021 (07.00 a.m. CET)
KBC Group: Third-quarter result of 601 million euros
Early in the third quarter, Belgium was confronted with the devastating consequences of heavy flooding in a number of provinces. We would once again like to express our heartfelt sympathy to everyone directly affected, as well as our deep appreciation to all the relief workers and volunteers who have been working tirelessly on behalf of the victims. We fully support the agreement reached following the talks held between Assuralia (the federation of the Belgian insurance sector) and the authorities, which provides greater security for all victims. Over the past few months, we have been using all our knowledge and expertise – via our broad network of insurance agents, experts and repairers – to ensure that the claims of the customers affected are settled quickly and properly. At the same time, the coronavirus crisis is still high on the agenda. In many countries, the large-scale rollout of vaccines is well under way or even in its final stages. Social life is gradually resuming, but caution is still paramount, as the virus is certainly not beaten yet. From the start of this crisis, we have taken responsibility in safeguarding the health of our staff and customers, while ensuring that services continue to be provided. We have also worked closely with government agencies to support all customers impacted by the coronavirus, implementing various measures such as loan payment holidays.
Over the past few months, we have signed a number of transactions that either strengthened or adjusted our geographic focus. At the end of July, for instance, we strengthened our share of the Bulgarian market by acquiring NN’s Bulgarian pension insurance and life insurance businesses. And at the end of August, we reached an agreement to dispose of substantially all of the non-performing mortgage loan portfolio of KBC Bank Ireland. More recently, we also entered into a legally binding agreement relating to the sale of substantially all of KBC Bank Ireland’s performing loan assets and its deposit book to Bank of Ireland Group. A small portfolio of non-performing mortgages will also be sold as part of that transaction. The transaction remains subject to regulatory – including Irish competition – approvals. The immediate one-off P&L impact in the third quarter of these Irish transactions amounted to -0.3 billion euros after tax, while there will be a positive impact of approximately 0.2 billion euros upon closure. The finalisation of both deals will ultimately lead to KBC withdrawing from the Irish market and will have a positive impact on our common equity ratio of approximately 0.9 percentage points.
Profit amounted to 601 million euros in the quarter under review, despite 319 million euros negative one-off impact related to the pending sale transactions in Ireland. Total income went up quarter-on-quarter, as higher net interest income, net fee and commission income and net other income more than offset the lower non-life insurance result (which had been negatively impacted by the floods in Belgium) and the seasonally lower level of dividend income. Excluding one-off and non-operating items (including forex effects and bank taxes), costs remained virtually stable quarter-on-quarter. Loan loss impairment contributed positively to the result, as the reversal of previously recorded impairment charges for the coronavirus crisis more than offset the negative impact on impairment of the pending sale transactions in Ireland. As announced earlier, we will pay an interim dividend of 3 euros per share on 17 November 2021, comprising 2 euros per share for financial year 2020 and 1 euro per share as an advance on the total dividend for financial year 2021.
Lastly, I would like to say a few words about our mobile app. In September, KBC Mobile was crowned best mobile banking app in the world by independent international research agency, Sia Partners. This is a clear recognition of 10 years of innovation, development and carefully listening to our customers. The Digital First approach we launched a year ago is clearly paying off and demonstrates the innovative strength we can harness as a group, with the ultimate goal of making our customers’ lives easier.
I would also like to take this opportunity to explicitly thank our customers and all other stakeholders for the trust they continue to put in us.
Chief Executive Officer
Full press release attached
AttachmentsTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
PCI Biotech and Immunicum Announce an Extension to Their Research Collaboration to Explore Novel Cancer Vaccination Treatments30.11.2021 08:00:00 CET | Press release
Oslo, Norway, November 30, 2021 - PCI Biotech Holding ASA (OSE: PCIB), a cancer focused biopharmaceutical company with a unique intracellular delivery technology via Photochemical Internalisation and Immunicum AB (publ; IMMU.ST), a biopharmaceutical company focused on hard-to-treat established tumors and the prevention of cancer recurrence, announced today an extension of their current collaboration. The companies jointly research the possibility to overcome current hurdles in cancer immunotherapy by introducing tumor independent immune targets into the tumor microenvironment, in combination with vaccination or adoptive immunotherapies. The so-called Tumor Independent Antigen concept, which has been invented by Immunicum, could benefit from PCI Biotech’s antigen delivery technologies based on Photochemical Internalisation. Following the encouraging results of the first set of in vitro experiments, during which the delivery protocol of the combination treatment has been optimized, the c
Progress on share buyback programme30.11.2021 08:00:00 CET | Press release
Progress on share buybackprogramme ING announced today that, in line with the launch of its €1,744 million share buyback programme announced on 1 October 2021, the company has repurchased 11,965,592 shares during the week of 22 November 2021 up to and including 26 November 2021. The shares were repurchased at an average price of €12.76 for a total amount of €152,726,167.76. For detailed information on the daily repurchased shares, individual share purchase transactions and weekly reports, see the ING website at https://www.ing.com/Investor-relations/Share-information/Share-buyback-programme.htm. The total number of shares repurchased under this programme to date is 63,890,733 ordinary shares at an average price of €12.95 for a total consideration of €827,691,629.18. To date approximately 47.46% of the maximum total value of the share buyback programme has been completed. Note for editors For further information on ING, please visit www.ing.com. Frequent news updates can be found in the
Ahold Delhaize share buyback update30.11.2021 08:00:00 CET | Press release
Zaandam, the Netherlands, November 30, 2021 – Ahold Delhaize has repurchased 2,510,000 of its common shares in the period from November 22, 2021 up to and including November 26, 2021. The shares were repurchased at an average price of €30.65 per share for a total consideration of €76.9 million. These repurchases were made as part of the €1 billion share buyback program announced on November 4, 2020. The total number of shares repurchased under this program to date is 33,090,599 common shares for a total consideration of € 832.6 million. Download the share buyback transactions excel sheet for detailed individual transaction information from https://www.aholddelhaize.com/en/investors/share-buyback-programs/2021/ This press release is issued in connection with the disclosure and reporting obligation set out in Article 2(2) of the EU Regulation that contains technical standards for buyback programs.
Ökat antal aktier och röster i Kinnevik30.11.2021 08:00:00 CET | Pressemelding
Kinnevik AB (publ) ("Kinnevik") meddelade idag att per den 30 november 2021 uppgår det totala antalet aktier i bolaget till 278.697.215, och det totala antalet röster i bolaget uppgår till 582.496.103. Ökningen beror på en nyemission av 853.550 omvandlingsbara, efterställda, incitamentsaktier av serierna C 2021 och D 2021, som i enlighet med vad som beslutades av extra bolagsstämman i oktober 2021 har överlåtits till deltagare i Kinneviks långsiktiga aktieincitamentsprogram 2021. Under november har Kinnevik även löst in 76.900 omvandlingsbara, efterställda incitamentsaktier som innehafts av före detta deltagare i Kinneviks långsiktiga incitamentsprogram som antogs av årsstämman 2019 respektive 2020. Per den 30 november 2021 är aktierna i Kinnevik fördelade i två stamaktieserier och tio incitamentsaktieserier enligt följande: 33.755.432 stamaktier av serie A med tio röster vardera och 242.153.584 stamaktier av serie B med en röst vardera, och297.258 incitamentsaktier av serie G 2018, 39
Kalmar and Holmen Iggesund deepen collaboration with inking of three-year Kalmar Care service agreement30.11.2021 08:00:00 CET | Press release
CARGOTEC CORPORATION, PRESS RELEASE, 30 NOVEMBER 2021 AT 9 AM (EET) Kalmar, part of Cargotec, has signed a three-year Kalmar Care service agreement with Holmen Iggesund, part of the Holmen Group. The contract, which covers the provision of maintenance services for all wheeled loading equipment at Iggesund Mill, was booked in Cargotec's 2021 Q4 order intake. The signed agreement will come into effect on 1 January 2022 and includes the option for a 12-month extension. One of the most advanced fully integrated pulp and paperboard mills in the world, Iggesund Mill on Sweden's east coast produces Invercote, one of the world's leading paperboard brands. The Kalmar Care service agreement will cover the maintenance of wheeled loading equipment including forklift trucks, terminal tractors and cranes. It covers the provision of equipment, operators and maintenance services as well as Kalmar Insight performance management software. Jon Stenberg, Head of Procurement, Holmen Iggesund: “As an indust
Increased Number of Shares and Votes in Kinnevik30.11.2021 08:00:00 CET | Press release
Kinnevik AB (publ) ("Kinnevik") today announced that as of 30 November 2021 the total number of shares in the company amounts to 278,697,215, and the total number of votes in the company amounts to 582,496,103. The increase is due to the new issue of 853,550 reclassifiable, sub-ordinated, incentive shares of classes C 2021 and D 2021, which, in accordance with the resolutions by the Extraordinary General Meeting in October 2021, have been transferred to participants in Kinnevik's 2021 long-term share incentive plan. During November Kinnevik also has also redeemed 76,900 reclassifiable, sub-ordinated incentive shares held by former participants in Kinnevik's long-term share incentive plans resolved by the 2019 and 2020 Annual General Meetings, respectively. As of 30 November 2021, the total number of shares in Kinnevik are divided into two classes of ordinary shares and ten classes of incentive shares as follows: 33,755,432 ordinary shares of class A with ten votes each and 242,153,584
Aegon to appoint Astrid Jäkel as Chief Risk Officer30.11.2021 08:00:00 CET | Press release
The Hague, November 30, 2021 - Aegon announced today that Astrid Jäkel (44, German) will be appointed as Chief Risk Officer (CRO) and member of the Management Board of Aegon N.V. effective March 1, 2022. Her responsibilities will include managing Aegon’s Group Risk and Actuarial functions, along with maintaining the Group’s Risk Management framework and overseeing the risk management capabilities. Astrid Jäkel joins Aegon from the international management consultancy firm Oliver Wyman where she has been a partner in the European Insurance and Asset Management Practice, co-leader of the European Insurance Financial Effectiveness team as well as a member of the Board of Oliver Wyman's Swiss subsidiary. Her consulting work has focused on high-impact risk, capital, asset liability and investment management topics. She has worked with leading European and global insurers on a broad range of projects to help transform and optimize their risk, finance, and investment capabilities. This includ